EOM Pharma Hldgs (OTC:IMUC) Stock, Quote.Headers.trade-ideas

EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve the lives of patients suffering from debilitating and sometimes deadly diseases. Its pipeline includes compound EOM613, an investigational novel dynamically dual-acting immunomodulator. EOM613 is a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad-spectrum cytokine effects.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAPL

APLT

ATKR

BPYPP

BVFL

CELP

CMRE

CNST

COWPP

EBSB

FABK

FDEF

FITBO

GNRC

GOLF

GOODN

HMCBF

HNGR

IMUC

IRET

KBAL

LTXB

MLRKF

MSEX

NDSN

PBBI

PDFS

PDIV

PPBI

QALB

QSMG

ROIC

RPAI

RQHTF

SALT

SIMA

SITC

SMED

SMTI

SPAR

STRL

TRCB

TRNS

UCBI

UCFC

VICI

ATZAF

SCTSF

ALLIF

EZEN

Stocks That Hit 52-Week Highs On Wednesday

Biotech

Earnings

AMGN

AXDX

BDSI

DOVA

ELAN

EVLO

GMXAY

JNCE

LJPC

MCRB

MRSN

ONCY

RMED

TBIO

TRIB

VBLT

The Daily Biotech Pulse: Enzo&#39;s Q4 Loss, Sanofi&#39;s Positive Trial Results, ImmunoCellular To Delist

Analyst Ratings

ADXS

CHKE

DMRC

DXTR

GLOB

KTOV

OCUL

PRPO

RSYS

RTNB

WPRT

15 Biggest Mid-Day Losers For Thursday

EOM PHARMACEUTICAL HLDNGS by EOM Pharmaceutical Holdings Inc.

EOM Pharma Hldgs

ImmunoCellular

Comments

EOM Pharma Hldgs

EOM Pharma Hldgs (OTC:IMUC) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell